Capillary leak syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Capillary leak syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References=...")
 
No edit summary
 
(9 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Capillary leak syndrome}}
{{Capillary leak syndrome}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [https://www.wikidoc.org/index.php/User:Hassan_M M. Hassan, M.B.B.S]


Please help WikiDoc by adding content hereIt's easy! Click [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Overview==
The pathogenesis of capillary leak syndrome remain unclear, however, '''[[cytokines]]''', '''[[vascular endothelial growth factor]]''' (VEGF), '''[[leukotrienes]]''', and '''complement''' play an important role.  During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count, as well as apoptosis of the endothelial cells.
 
==Pathophysiology==
Capillary leak syndrome also known as '''''Clarkson's disease''''' and '''''spontaneous periodic edema''''' is a life threatening condition characterized by recurrent episodes of [[hypovolemic shock]], [[hemoconcentration]], and [[hypoalbuminemia]], occurring in the absence of [[albuminuria]].   
 
The pathogenesis of capillary leak syndrome remain unclear, however, '''[[cytokines]]''', '''[[vascular endothelial growth factor]]''' (VEGF), '''[[leukotrienes]]''', and '''complement''' play an important role.  During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count. The exact cause of hyperpermeability remains unknown, and protein up to 900 kDa can extravasate from the intravascular to interstitial space. During the hyperpermeability episode, endothelial cells undergo [[apoptosis]], which is characterized by endothelial microvascular body and bleb formation. <ref name="pmid20634497">{{cite journal| author=Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC | display-authors=etal| title=Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 10 | pages= 905-12 | pmid=20634497 | doi=10.4065/mcp.2010.0159 | pmc=2947962 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20634497  }} </ref>


==References==
==References==
Line 12: Line 19:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
 
[[Category:Needs English Review]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 15:26, 18 August 2022

Capillary leak syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Capillary leak syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Capillary leak syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Capillary leak syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Capillary leak syndrome pathophysiology

CDC on Capillary leak syndrome pathophysiology

Capillary leak syndrome pathophysiology in the news

Blogs on Capillary leak syndrome pathophysiology

Directions to Hospitals Treating Capillary leak syndrome

Risk calculators and risk factors for Capillary leak syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S

Overview

The pathogenesis of capillary leak syndrome remain unclear, however, cytokines, vascular endothelial growth factor (VEGF), leukotrienes, and complement play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count, as well as apoptosis of the endothelial cells.

Pathophysiology

Capillary leak syndrome also known as Clarkson's disease and spontaneous periodic edema is a life threatening condition characterized by recurrent episodes of hypovolemic shock, hemoconcentration, and hypoalbuminemia, occurring in the absence of albuminuria.

The pathogenesis of capillary leak syndrome remain unclear, however, cytokines, vascular endothelial growth factor (VEGF), leukotrienes, and complement play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count. The exact cause of hyperpermeability remains unknown, and protein up to 900 kDa can extravasate from the intravascular to interstitial space. During the hyperpermeability episode, endothelial cells undergo apoptosis, which is characterized by endothelial microvascular body and bleb formation. [1]

References

  1. Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC; et al. (2010). "Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience". Mayo Clin Proc. 85 (10): 905–12. doi:10.4065/mcp.2010.0159. PMC 2947962. PMID 20634497.

Template:WikiDoc Sources